{
  "docId": "019dd923-5fed-74f2-a970-22e81ff63ce8",
  "docSlug": "bi-afad71c64ca4f4b7",
  "documentTitle": "Meliora Therapeutics pitch deck: $11 million seed round",
  "authorId": "Pitchdecks",
  "authorName": "Meliora Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 13,
  "pageCount": 14,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "use_of_funds",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "action_title",
    "process_diagram",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a970-22e81ff63ce8/13",
  "deckHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "SEED ROUND GOAL: ROBUST PIPELINE OF TARGETED THERAPY STARTING SCAFFOLDS WHICH DEMONSTRATES FEASIBILITY OF OUR COMPUTATIONAL APPROACH",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b0-71fc-abf9-51f3e56caef9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.05,
        "y": 0.275
      },
      "kind": "diagram",
      "text": "Seed Round Financing leading to Platform and Pipeline",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb086b29-121b-4f47-9f82-c3c48f87ea4f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.4,
        "y": 0.58
      },
      "kind": "list",
      "text": "Nominate additional precision medicine oncology programs with commercial potential, in vitro validation data, and clear path to IP feasibility",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be15005b-46ae-43e8-8e70-064780348f20",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.4,
        "y": 0.28
      },
      "kind": "list",
      "text": "Expand data science team to grow platform capabilities; Generate proprietary data inputs for molecular map; Key hires: computational platform development, drug development",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdd49e2d-2d0c-432a-b23e-602ada23b106",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.81
      },
      "kind": "title",
      "text": "SEED ROUND GOAL: ROBUST PIPELINE OF TARGETED THERAPY STARTING SCAFFOLDS WHICH DEMONSTRATES FEASIBILITY OF OUR COMPUTATIONAL APPROACH",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ba5db90-b600-41b7-86ff-2dbf29fbe58a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "title",
      "text": "SEED ROUND USE OF PROCEEDS: MELIORA AIMS TO EXPAND PLATFORM CAPABILITIES AND IDENTIFY A PIPELINE OF COMPOUNDS WITH STRONG DRUG DEVELOPMENT POTENTIAL",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed43789f-4cce-444c-a508-66ccb6283fb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 12,
      "beatId": "1eff3344-1498-41f6-97b3-731068827ee9",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Use of Funds",
      "beatSlug": null,
      "evidence": "Seed round use of proceeds and company milestones",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}